長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4534】持田製薬

【4534】持田製薬
製薬。循環器。婦人科。
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 杏林製薬 ゼリア新薬工業


東証プライム
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/01 Q2予 106,000 → 0.0% 0.0% 7,500 → 0.0% 0.0% 7,700 → 0.0% 0.0% 5,600 → 0.0% 0.0%
2025.03 2024/08/02 Q1予 106,000 → 0.0% 0.0% 7,500 → 0.0% 0.0% 7,700 → 0.0% 0.0% 5,600 → 0.0% 0.0%
2025.03 2024/05/13 当初予 106,000 - - - 7,500 - - - 7,700 - - - 5,600 - - -
2024.03 2024/05/13 実 102,885 ↑ +0.9% -1.1% 5,802 ↑ +5.5% -31.7% 6,037 ↑ +5.9% -30.6% 4,547 ↑ +3.3% -27.8%
2024.03 2024/02/05 Q3予 102,000 ↓ -1.9% -1.9% 5,500 ↓ -35.3% -35.3% 5,700 ↓ -34.5% -34.5% 4,400 ↓ -30.2% -30.2%
2024.03 2023/11/02 Q2予 104,000 → 0.0% 0.0% 8,500 → 0.0% 0.0% 8,700 → 0.0% 0.0% 6,300 → 0.0% 0.0%
2024.03 2023/08/04 Q1予 104,000 → 0.0% 0.0% 8,500 → 0.0% 0.0% 8,700 → 0.0% 0.0% 6,300 → 0.0% 0.0%
2024.03 2023/05/15 当初予 104,000 - - - 8,500 - - - 8,700 - - - 6,300 - - -
2023.03 2023/05/15 実 103,261 ↓ -1.7% -1.7% 8,507 ↑ +0.1% +0.1% 9,085 ↑ +3.2% +3.2% 6,649 ↑ +3.9% +3.9%
2023.03 2023/02/06 Q3予 105,000 → 0.0% 0.0% 8,500 → 0.0% 0.0% 8,800 → 0.0% 0.0% 6,400 → 0.0% 0.0%
2023.03 2022/11/04 Q2予 105,000 → 0.0% 0.0% 8,500 → 0.0% 0.0% 8,800 → 0.0% 0.0% 6,400 → 0.0% 0.0%
2023.03 2022/08/01 Q1予 105,000 → 0.0% 0.0% 8,500 → 0.0% 0.0% 8,800 → 0.0% 0.0% 6,400 → 0.0% 0.0%
2023.03 2022/05/13 当初予 105,000 - - - 8,500 - - - 8,800 - - - 6,400 - - -
2022.03 2022/05/13 実 110,179 ↑ +1.1% +8.6% 14,392 ↑ +10.7% +79.9% 14,799 ↑ +10.4% +78.3% 10,569 ↑ +11.3% +76.2%
2022.03 2022/02/04 Q3予 109,000 → 0.0% +7.4% 13,000 → 0.0% +62.5% 13,400 → 0.0% +61.4% 9,500 → 0.0% +58.3%
2022.03 2022/01/31 修正予 109,000 ↑ +2.3% +7.4% 13,000 ↑ +30.0% +62.5% 13,400 ↑ +28.8% +61.4% 9,500 ↑ +28.4% +58.3%
2022.03 2021/11/05 修正予 106,500 ↑ +4.9% +4.9% 10,000 ↑ +25.0% +25.0% 10,400 ↑ +25.3% +25.3% 7,400 ↑ +23.3% +23.3%
2022.03 2021/07/30 Q1予 101,500 → 0.0% 0.0% 8,000 → 0.0% 0.0% 8,300 → 0.0% 0.0% 6,000 → 0.0% 0.0%
2022.03 2021/05/14 当初予 101,500 - - - 8,000 - - - 8,300 - - - 6,000 - - -
2021.03 2021/05/14 実 102,995 ↑ +0.1% +1.0% 12,003 ↑ +0.0% +53.9% 12,260 ↑ +0.5% +49.5% 8,587 ↑ +1.0% +48.1%
2021.03 2021/05/10 修正予 102,900 ↑ +0.9% +0.9% 12,000 ↑ +20.0% +53.8% 12,200 ↑ +18.4% +48.8% 8,500 ↑ +14.9% +46.6%
2021.03 2021/02/05 Q3予 102,000 → 0.0% 0.0% 10,000 → 0.0% +28.2% 10,300 → 0.0% +25.6% 7,400 → 0.0% +27.6%
2021.03 2021/02/01 修正予 102,000 → 0.0% 0.0% 10,000 ↑ +28.2% +28.2% 10,300 ↑ +25.6% +25.6% 7,400 ↑ +27.6% +27.6%
2021.03 2020/11/02 Q2予 102,000 → 0.0% 0.0% 7,800 → 0.0% 0.0% 8,200 → 0.0% 0.0% 5,800 → 0.0% 0.0%
2021.03 2020/07/31 Q1予 102,000 → 0.0% 0.0% 7,800 → 0.0% 0.0% 8,200 → 0.0% 0.0% 5,800 → 0.0% 0.0%
2021.03 2020/05/15 当初予 102,000 - - - 7,800 - - - 8,200 - - - 5,800 - - -
2020.03 2020/05/15 実 101,799 ↑ +0.1% -1.2% 8,807 ↑ +1.2% +14.4% 9,154 ↑ +0.6% +13.0% 4,598 ↑ +2.2% -20.7%
2020.03 2020/04/24 修正予 101,700 ↑ +0.7% -1.3% 8,700 ↑ +24.3% +13.0% 9,100 ↑ +23.0% +12.3% 4,500 ↑ +40.6% -22.4%
2020.03 2020/03/30 修正予 101,000 ↓ -1.9% -1.9% 7,000 ↓ -9.1% -9.1% 7,400 ↓ -8.6% -8.6% 3,200 ↓ -44.8% -44.8%
2020.03 2020/02/07 Q3予 103,000 → 0.0% 0.0% 7,700 → 0.0% 0.0% 8,100 → 0.0% 0.0% 5,800 → 0.0% 0.0%
2020.03 2019/11/05 Q2予 103,000 → 0.0% 0.0% 7,700 → 0.0% 0.0% 8,100 → 0.0% 0.0% 5,800 → 0.0% 0.0%
2020.03 2019/08/02 Q1予 103,000 → 0.0% 0.0% 7,700 → 0.0% 0.0% 8,100 → 0.0% 0.0% 5,800 → 0.0% 0.0%
2020.03 2019/05/13 当初予 103,000 - - - 7,700 - - - 8,100 - - - 5,800 - - -
2019.03 2019/05/13 実 109,643 ↓ -0.8% -0.3% 10,590 ↑ +17.7% +51.3% 10,928 ↑ +16.3% +49.7% 8,435 ↑ +5.4% +31.8%
2019.03 2019/02/08 Q3予 110,500 → 0.0% +0.5% 9,000 → 0.0% +28.6% 9,400 → 0.0% +28.8% 8,000 → 0.0% +25.0%
2019.03 2019/02/04 修正予 110,500 ↑ +0.5% +0.5% 9,000 ↑ +28.6% +28.6% 9,400 ↑ +28.8% +28.8% 8,000 ↑ +25.0% +25.0%
2019.03 2018/11/05 Q2予 110,000 → 0.0% 0.0% 7,000 → 0.0% 0.0% 7,300 → 0.0% 0.0% 6,400 → 0.0% 0.0%
2019.03 2018/08/03 Q1予 110,000 → 0.0% 0.0% 7,000 → 0.0% 0.0% 7,300 → 0.0% 0.0% 6,400 → 0.0% 0.0%
2019.03 2018/05/14 当初予 110,000 - - - 7,000 - - - 7,300 - - - 6,400 - - -
2018.03 2018/05/14 実 106,761 ↑ +0.1% -0.2% 11,662 ↑ +0.5% +16.6% 12,008 ↑ +0.1% +16.6% 9,023 ↑ +0.3% +20.3%
2018.03 2018/04/23 修正予 106,700 ↓ -0.3% -0.3% 11,600 ↑ +16.0% +16.0% 12,000 ↑ +16.5% +16.5% 9,000 ↑ +20.0% +20.0%
2018.03 2018/02/05 Q3予 107,000 → 0.0% 0.0% 10,000 → 0.0% 0.0% 10,300 → 0.0% 0.0% 7,500 → 0.0% 0.0%
2018.03 2017/10/30 Q2予 107,000 → 0.0% 0.0% 10,000 → 0.0% 0.0% 10,300 → 0.0% 0.0% 7,500 → 0.0% 0.0%
2018.03 2017/07/31 Q1予 107,000 → 0.0% 0.0% 10,000 → 0.0% 0.0% 10,300 → 0.0% 0.0% 7,500 → 0.0% 0.0%
2018.03 2017/05/15 当初予 107,000 - - - 10,000 - - - 10,300 - - - 7,500 - - -
2017.03 2017/05/15 実 97,349 ↑ +1.9% +7.0% 11,374 ↑ +11.5% +42.2% 11,648 ↑ +10.9% +42.0% 8,526 ↑ +12.2% +52.3%
2017.03 2017/01/30 Q3予 95,500 → 0.0% +4.9% 10,200 → 0.0% +27.5% 10,500 → 0.0% +28.0% 7,600 → 0.0% +35.7%
2017.03 2016/10/31 Q2予 95,500 ↑ +4.9% +4.9% 10,200 ↑ +27.5% +27.5% 10,500 ↑ +28.0% +28.0% 7,600 ↑ +35.7% +35.7%
2017.03 2016/07/29 Q1予 91,000 → 0.0% 0.0% 8,000 → 0.0% 0.0% 8,200 → 0.0% 0.0% 5,600 → 0.0% 0.0%
2017.03 2016/05/13 当初予 91,000 - - - 8,000 - - - 8,200 - - - 5,600 - - -
2016.03 2016/05/13 実 92,272 ↑ +0.1% +2.5% 12,154 ↑ +0.4% +21.5% 12,392 ↑ +0.7% +21.5% 8,150 ↑ +0.6% +16.4%
2016.03 2016/04/25 修正予 92,200 ↑ +2.4% +2.4% 12,100 ↑ +21.0% +21.0% 12,300 ↑ +20.6% +20.6% 8,100 ↑ +15.7% +15.7%
2016.03 2016/02/01 Q3予 90,000 → 0.0% 0.0% 10,000 → 0.0% 0.0% 10,200 → 0.0% 0.0% 7,000 → 0.0% 0.0%
2016.03 2015/10/30 Q2予 90,000 → 0.0% 0.0% 10,000 → 0.0% 0.0% 10,200 → 0.0% 0.0% 7,000 → 0.0% 0.0%
2016.03 2015/07/31 Q1予 90,000 - - - 10,000 - - - 10,200 - - - 7,000 - - -
2015.03 2015/01/30 Q3予 86,500 → 0.0% -8.9% 9,400 → 0.0% -36.5% 9,600 → 0.0% -36.0% 6,300 → 0.0% -37.0%
2015.03 2014/10/31 Q2予 86,500 → 0.0% -8.9% 9,400 → 0.0% -36.5% 9,600 → 0.0% -36.0% 6,300 → 0.0% -37.0%
2015.03 2014/10/14 修正予 86,500 ↓ -8.9% -8.9% 9,400 ↓ -36.5% -36.5% 9,600 ↓ -36.0% -36.0% 6,300 ↓ -37.0% -37.0%
2015.03 2014/07/28 Q1予 95,000 → 0.0% 0.0% 14,800 → 0.0% 0.0% 15,000 → 0.0% 0.0% 10,000 → 0.0% 0.0%
2015.03 2014/05/12 当初予 95,000 - - - 14,800 - - - 15,000 - - - 10,000 - - -
2014.03 2014/05/12 実 93,947 - - - 16,600 - - - 16,799 - - - 9,892 - - -
シェア ツイート
ページトップへ戻る